98%
921
2 minutes
20
Background: The harmful effects of high-intensity (HI) and long duration (LD) exercise have been reported in arrhythmogenic right ventricular cardiomyopathy, including in asymptomatic genetic variant carriers. However, the impact of exercise remains unclear in desmoplakin (DSP) gene variant carriers at risk of arrhythmogenic left ventricular cardiomyopathy (ALVC).
Objectives: The goal of this study was to assess the relationship between HI and LD exercise and the risk of developing an ALVC phenotype and its severity in DSP variant carriers.
Methods: In a monocentric retrospective study, patients with DSP pathogenic or likely pathogenic variant were interviewed about their exercise practice before genetic or disease diagnosis. HI and LD exercise were defined as having practiced at least one sport with an intensity ≥6 METs and ≥2.5 hours/week, respectively. We studied the association of HI and LD exercise practice with the risk of ALVC phenotype occurrence at diagnosis.
Results: A total of 85 patients were included (mean age 39 ± 19 years; 49% female). Sixty-nine percent had practiced HI exercise and 66% LD exercise. The rate of patients with an ALVC phenotype at time of diagnosis did not differ between patients having practiced HI and LD exercise and those who had not (71% vs 65% [P = 0.60] and 70% vs 69% [P = 0.95]). The distribution of prior calculated exercise dose was not different between patients with vs those without ALVC phenotype at diagnosis (P = 0.57).
Conclusions: Prior exercise intensity, duration, and cumulated lifetime dose were not associated with an increased risk of developing an ALVC phenotype at the time of diagnosis in DSP variant carriers.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacep.2025.05.007 | DOI Listing |
JACC Clin Electrophysiol
June 2025
Cardiology Department, Nantes Université, CHU Nantes, INSERM, l'institut du Thorax, Nantes, France. Electronic address:
Background: The harmful effects of high-intensity (HI) and long duration (LD) exercise have been reported in arrhythmogenic right ventricular cardiomyopathy, including in asymptomatic genetic variant carriers. However, the impact of exercise remains unclear in desmoplakin (DSP) gene variant carriers at risk of arrhythmogenic left ventricular cardiomyopathy (ALVC).
Objectives: The goal of this study was to assess the relationship between HI and LD exercise and the risk of developing an ALVC phenotype and its severity in DSP variant carriers.
Br J Hosp Med (Lond)
March 2025
Department of Cardiology, Queen Elizabeth University Hospital, Glasgow, UK.
Arrhythmogenic cardiomyopathy (ACM) is a genetically inherited cardiomyopathy characterised by the fibro-fatty replacement of the myocardium. Patients can present with symptoms of arrhythmia or heart failure; it is a common cause of sudden cardiac arrest and death in young adults. Originally considered as right ventricular arrhythmogenic cardiomyopathy or dysplasia, this terminology has been updated to include left-dominant and biventricular phenotypes.
View Article and Find Full Text PDFBMC Cardiovasc Disord
August 2024
Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Background: Arrhythmogenic cardiomyopathy (ACM) characterized by progressive myocardial loss and replacement with fibro-fatty tissue is a major cause of sudden cardiac death (SCD). In particular, ACM with predominantly left ventricular involvement, known as arrhythmogenic left ventricular cardiomyopathy (ALVC), has a poor prognosis.
Methods: The proband underwent whole-exome sequencing (WES) to determine the etiology of ALVC.
J Am Soc Echocardiogr
October 2024
Nantes Université, CHU Nantes, INSERM, Cardiology Department, CIC 1413, l'Institut du Thorax, Nantes, France. Electronic address:
Background: Arrhythmogenic left ventricular cardiomyopathy (ALVC) is characterized by fibrofatty myocardial replacement demonstrated on cardiac magnetic resonance by late gadolinium enhancement (LGE) mainly involving the subepicardium. The aims of this study were to describe the layer-specific strain (LSS) echocardiography phenotype of ALVC and to compare it with LGE features.
Methods: All consecutive ALVC pathogenic genetic variant carriers and noncarrier relatives were separated into four prespecified groups (overt ALVC [group 1], isolated LGE [group 2], pathogenic genetic variant carrier without ALVC phenotype [group 3], and no genetic variant carrier [group 4]) and studied accordingly using cardiac magnetic resonance and LSS echocardiography.
J Clin Med
March 2024
Cardiology Unit, Department of Medical Translational Science, University of Campania "Luigi Vanvitelli"-"V. Monaldi" Hospital, 80126 Naples, Italy.